Danny Deutsch’s Post

I'm thrilled to share some exciting news with you all! I've been appointed to the advisory board of Inside Precision Medicine, and it's truly an honor to join such a distinguished group of industry leaders, including Phillip G. Febbo, MD, Chief Medical Officer at Veracyte, Inc., David Smith, Ph.D., Professor of Laboratory Medicine and Pathology at Mayo Clinic, and Amit Rastogi, MD, MHCM, President & CEO at Jupiter Medical Center. With over two decades of experience driving innovation in healthcare and life sciences, I've witnessed firsthand the transformative power that innovative technology and health data can have on patient outcomes. Throughout my career, I've been driven by a relentless dedication to placing patients at the heart of everything we do. From pioneering genetic testing 🧬 solutions to advocating for patient rights, my journey has been guided by a deep-seated belief in the importance of 👉 patient-centricity. Now, as a member of the advisory board of Inside Precision Medicine, I'm more committed than ever to championing this ethos. I believe that by prioritizing the needs and perspectives of patients, we can truly transform precision medicine. This means not only leveraging cutting-edge technologies and data but also ensuring that these tools are accessible, understandable, and empowering for both patients and researchers. By bridging the gap between healthcare providers, researchers, and patients, we can create a more collaborative and effective ecosystem for precision medicine. Together, we have the opportunity to redefine healthcare delivery, empower individuals to take control of their health journey, and ultimately, improve outcomes for all. Link to the announcement: https://shorturl.at/benG2 #DigitalHealth #Leadership #PrecisionMedicine #ClinicalTrials #Healthcare #LifeSciences #Genomics

🌟Precision Harmony: Orchestrating Collaborative Synergy in Precision Medicine's Evolution We are glad to introduce you to a very special series of publications… Circular-Lab’s Monthly Expert Topic!!🩵 In these downloadable publications, expert members of our scientific and IT teams will discuss exciting and valuable topics related to the healthcare and new emerging technologies sector. All of these, from a more professional and unique perspective, as they are knowledgeable about this entire universe and will be able to provide us with fascinating insights from within the ecosystem to which they belong. This month, we will approach one of the pillars that build our company, more differently and originally... Welcome to the Symphony of Precision Medicine. 🔬 We wanted to express our sincere thanks to Camille Garnier, Circular-Lab VP of Precision Medicine, for sharing his knowledge and experience with our community and explaining this topic in such an engaging and understandable way. See you with a new monthly expert topic in May!!!🚀 #MonthlyExpertTopic #Precisionmedicine #Personalizedcare #Precisiononcology #Healthcare #Biomarkertesting

Conference time in Lausanne!! Yesterday, I attended the FutureHealth Lausanne summit, where cutting-edge science intersected with crucial discussions on the investor landscape and policy. Here are some of the highlights that caught my attention: 💡 Cyrill Gyger's QUMEA introduced a non-intrusive AI-driven patient monitoring device that detects even the subtlest movements such as breathing, enhancing patient safety by preventing falls and promptly notifying medical staff in hospitals. I love that this technology is totally in line with privacy and data regulation policies. 💡 HAYA Therapeutics is exploring the hidden potential of "junk" DNA to combat fibrotic diseases. Great to chat with Daniel Blessing on their work on HTX-001, an antisense oligonucleotide targeting a long-non coding RNA called wisper. It has demonstrated promising results in reducing fibrosis and enhancing heart function in preclinical models. 💡 domo.health and Tarik Dlala showcased an innovative fusion of medical note-taking and digital health platforms, revolutionizing home visits for caregivers and empowering patients to proactively manage their health. 💡 Kallol Mukherji's poignant reminder urged us to share our innovations globally to bridge health disparities and uplift those in need. Terre des hommes foundation #FutureHealth #FHL24

Committed to Quality and Transparency in Regenerative Medicine At Lumm, our priority is ensuring quality and clarity in everything we do. We're excited to share how our quality assurance program is making a difference in the field of regenerative medicine. 🔍 Quality as a Priority: Our program adheres to international standards and guidelines. We conduct internal audits and seek external accreditations to maintain the highest level of quality in our research and treatments. 🤝 Collaboration and Benchmarking: We actively participate in industry associations and conferences, benchmarking against best practices to continuously improve our approaches and outcomes. 📊 Clear Communication: We present our results with accuracy and simplicity, ensuring they are easily understandable for patients and caregivers. Transparency is key to building trust in the transformative potential of regenerative medicine. We're proud of the steps we're taking at Lumm to ensure quality and transparency in this cutting-edge field. Let's connect and explore how we can work together to advance regenerative medicine! #QualityAssurance #Transparency #RegenerativeMedicine #Collaboration

since 2015 iBET - Instituto de Biologia Experimental e Tecnológica is proudly part of iNOVA4Health - a translational research program! Big achievements are possible by fostering collaborations between 5 institutions while respecting each institution unique identity! Major challenge and the KEY for our success: integration of our complementarities! iNOVA4Health is unique! We will keep doing what we love most…R&D

Are you up to date on global oral health market trends? 👇 Our inaugural report, drawn from PitchBook datasets, surfaces and analyzes trends in VC investment across oral health worldwide. Explore the latest developments, deal activity, key innovations, future expectations, and what it all means: https://ow.ly/tXtV50UkZGL #oralhealth #innovation #oralhealthishealth

We are delighted to join our partners at ABHI US Accelerator for another trade visit to the US! This week, we’re heading to the sunshine state of Florida. Over the coming days, our Head of US Commercial, Paul Carson, will be visiting healthcare providers in Orlando, Tampa, and Miami to showcase our innovative work in digitising patient care and optimising hospital workflows. To learn more about our digital solutions and how we can support you and your patients, please visit our website. #ABHI #ABHIUSAccelerator #HealthTech #DigitalHealth #DigitalTransformation

BIG NEWS for #Wisconsin! "The Wisconsin Biohealth Tech Hub, led by BioForward, Inc. Wisconsin, achieves a significant milestone as a Phase 2 recipient of the @U.S. Department of Commerce’s U.S. Economic Development Administration (EDA) Regional Technology and Innovations Hub (Tech Hub) program, affirming Wisconsin’s leadership in #biohealth #technology and #personalizedmedicine. Following a rigorous selection process, the EDA has awarded the Wisconsin Biohealth Tech Hub with $49 million in federal grants to support transformative projects aligned with the program’s overarching goal. Alongside this, an additional $7.5 million in state funding and $24 million in #industry commitments have been secured, bringing the total funding and commitments to over $80 million. This substantial investment will fuel projects to advance personalized medicine, enhance #healthcare outcomes, and drive economic development across Wisconsin. 'We are thrilled to receive a Phase 2 award for the Wisconsin Biohealth Tech Hub,” said Wendy Harris, Regional Innovation Officer. 'This #funding will enable us to accelerate the development and deployment of cutting-edge biohealth solutions, positioning Wisconsin as a global leader in personalized medicine.' Building on the momentum of Phase 1 designation, the Wisconsin Biohealth Tech Hub is poised to expand its impact and drive #innovation in key areas such as imaging/theranostics, #genomics, and big data/analytics. Leveraging strategic partnerships and collaborative efforts, the Tech Hub will focus on initiatives to enhance manufacturing coordination, advance critical genomic technology, and foster talent development in the biohealth sector." The University of Wisconsin-Madison serves as a key partner in the Tech Hub effort. “Collaboration has been key to success for the Wisconsin Biohealth Tech Hub. This unique and multi-disciplinary collaboration is unprecedented, and all consortium members are working together in the best interests of Wisconsin and the world.” - Kurt J. Zimmerman, senior director, Office of Biohealth Industry Partnerships, UW SMPH Press Release: 'Wisconsin Biohealth Tech Hub secures Phase 2 award, catalyzing innovation and economic growth' https://lnkd.in/g9MTEAxg via BioForward #biotech #leadership #OnWisconsin

It’s been a good day 💃 We’re thrilled to announce that we’ve moved onto Phase II of the Roche MS Innovation Challenge! It’s an honor to be part of this small group, selected from investigator submissions that spanned 32 countries 💪🏻 The MS Innovation Challenge supports researchers and #startups building innovative responses to help those living with #MultipleSclerosis. Its primary focuses are: 🩺 Providing early detection of disease to drive earlier treatment 👀 Improving monitoring and prediction of the impact of disease on individuals Our long-term company mission has always been to harness #technology to aid in earlier disease detection and prognostication — moving forward in this challenge is an exciting testament to the research work we’re doing and the larger-scale opportunities it has to transform #healthcare. Learn more about the challenge and the criteria for evaluation here: https://lnkd.in/gW-6EW3E 📸 Photo from last year's company retreat, but our amount of excitement is the same! #healthcare #optometry

🎉 Exciting news from ZetrOZ Systems! They've just secured a grant from the U.S. Department of Health and Human Services (HHS), specifically the The National Institutes of Health, to further their groundbreaking work in knee osteoarthritis treatment. This award is part of the Small Business Innovation Research Program Phase I, and while the contract amount is listed as $0.0, the value of the research is immeasurable. 🦵 Zetroz Systems is pioneering a novel sonophoresis patch that combines ultrasound with topical NSAIDs to enhance pain relief for knee osteoarthritis sufferers. Their innovative approach has already shown promising results, significantly reducing knee pain and improving mobility. This project aims to bring a non-invasive, non-opioid treatment option to patients, regardless of their background or location. 📅 The research, which is set to last for 32 months, kicks off on January 1, 2024, and will conclude on May 31, 2027. This initiative is a testament to the power of innovation in healthcare. #SBIR #STTR #Innovation #Healthcare #Osteoarthritis